Interleukin-12 (IL-12 P70) ELISA Kit
- Created on the 12 March, 2017.
INTENDED USE
Interleukin-12 ELISA kit can be used to analyse in vitro quantitative levels of interleukin-12 p70 (IL-12 p70) in human serum and cell culture supernatant. This assay has a minimum detection limit of < 2.0 pg/ml.
BACKGROUND
Interleukin-12 (IL-12) is a pleiotropic cytokine which also use to be called natural killer cell stimulatory factor (NKSF) and cytotoxic lymphocyte maturation factor (CLMF), is primarily produced by stimulated macrophages. It is a 70-KDa cytokine that is composed of two disulfide-linked proteins (p35 and p40), IL-12p70 is a heterodimer of p35 and p40 subunits and it is a vital cytokine that is secreted by antigen-presenting cells in response to antigenic stimulation. Gene expression studies have indicated that both strains of the IL-12 cytokine family can induce high levels of p40 (protein chain that is communal to both IL-12 p70 and IL-23) and p19 (a subunit of IL-23). Conversely it was found that only infection with ACT-18HS19 were able to consistently induced the transcription of IL-12 p35 (a subunit of IL-12 p70).
Interleukin-12 was originally discovered as factor being produced by human Epstein-Barr-Virus transformed B cell lines. It was also shown to be a pro-inflammatory cytokine that can be produced by B cells, phagocytic cells and many antigen-presenting cells that have the ability to modulate the adaptive immune responses by generating T-helper type 1 cells. IL-12 can exert a number of different biological effects on natural killer cells and human T cells. There is a strong suggestion of a potential usefulness in cancer therapy, due to its ability to direct the development of a Th1 type immune response from naive T cells indicating a critical role in regulating an immune response. Increased plasma levels of IL-12 have been found in neurological disorders and a significant elevations have been measured in patients with multiple sclerosis, autistic, rheumatoid arthritis, seronegative spondylarthropathies and osteoarthritis. The standard used in the following interleukin-12 ELISA kit is recombinant human IL-12 p70 that has a total molecular mass of 75 KDa.
SENSITIVITY
The minimum detection sensitivity level of IL-12 p70 using current human interleukin-12 ELISA kit was approximately 2.0 pg/ml. The dynamic range for this assay is 7.8 – 500 pg/ml.
REFERENCES
- Genetic variations in interleukin-12 related genes in immune-mediated diseases. J Autoimmun. (2012) 39 (4): 359-68. Review. van Wanrooij R.L., et al.
- Stepwise regulation of TH1 responses in autoimmunity: IL-12-related cytokines and their receptors. Inflamm Bowel Dis. (2005) 11 (8): 755-64. Review. Becker C., et al.
- Novel IL-12 family members shed light on the orchestration of Th1 responses. Trends Immunol. (2003) 24 (4): 207-12. Review. Brombacher F., et al
- IL-12: the role ofp40versus p75. Scand J Immunol. (2002) 56 (1): 1-11. Review. Abdi K.
- Interleukin-12: Functional activities and implications for disease. Cytokine Growth Factor Rev. (2015) 26 (5): 559-68. Review. Zundler S. and Neurath M.F.
- Inhibiting cytokines of the interleukin-12 family: recent advances and novel challenges. J Pharm Pharmacol. (2004) 56 (2): 145-60. Review. Vandenbroeck K., et al.
ADDITIONAL INFORMATION
- Full Name: Interleukin-12 (IL-12 P70) ELISA Kit
- Reactivity: Human
- Sample Type: Serum, Cell Culture Supernatant
- Sensitivity: < 2.0 pg/ml
